ATHXQ — Athersys Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.77m
- $5.33m
Annual cashflow statement for Athersys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.3 | -44.6 | -78.8 | -87 | -72.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.63 | 4.85 | 7.38 | 8.79 | 9.21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.45 | 3.71 | 8.69 | 0.552 | 2.95 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.3 | -35.3 | -61.8 | -76.2 | -59 |
| Capital Expenditures | -1.53 | -0.579 | -1.16 | -1.36 | -0.397 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.617 | 0 | 0 | — | 0.135 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.915 | -0.579 | -1.16 | -1.36 | -0.262 |
| Financing Cash Flow Items | 20.6 | -0.424 | 6.7 | -0.857 | -0.179 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 36 | 19.9 | 79.5 | 63.4 | 30.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.7 | -16 | 16.5 | -14.1 | -28.4 |